Related Experiment Video
Updated: Jul 10, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
[Species composition of yeast-like fungi isolated from HIV-infected patients]
Abstract:
The strains of yeast-like fungi isolated from HIV-infected people in 1994-2005 were examined. It was found that a share of non-albicans strains increased up to 46.2%, in monoculture they were present in 40% of examined patients, Candida glabrata (21.3%) being the dominant species. The definition of proteolytic activity as one of the factors of pathogenicity showed that it was typical of 90% of museum strains and 58% of fresh isolates.
Insights
The proportion of non-albicans yeast strains in HIV-infected individuals increased significantly. Candida glabrata emerged as the dominant species, with many strains exhibiting proteolytic activity, a key pathogenicity factor.
Area of Science:
- Medical Mycology
- Infectious Diseases
- HIV/AIDS Research
Context:
- Yeast-like fungi infections in Human Immunodeficiency Virus (HIV)-infected populations.
- Longitudinal study spanning 1994-2005 to track fungal strain prevalence.
- Focus on opportunistic fungal infections in immunocompromised individuals.
Purpose:
- To analyze the changing prevalence of non-albicans yeast strains in HIV-infected patients over time.
- To identify the dominant yeast species and assess their pathogenic potential.
- To investigate the role of proteolytic activity as a virulence factor in these fungal isolates.
Summary:
- Analysis of yeast-like fungi from HIV-infected patients between 1994 and 2005 revealed a rise in non-albicans strains to 46.2%.
- Non-albicans strains were found in monoculture in 40% of patients, with Candida glabrata being the most prevalent species (21.3%).
- Proteolytic activity, a significant pathogenicity factor, was detected in 90% of reference strains and 58% of newly isolated strains.
Impact:
- Highlights a critical shift in the etiological agents of fungal infections within the HIV-infected population.
- Identifies Candida glabrata as a species of increasing clinical importance in this demographic.
- Provides insights into fungal virulence mechanisms, potentially guiding future therapeutic strategies against opportunistic mycoses in immunocompromised patients.
Related Concept Videos
Fungal Group Zygomycota
Cryptococcal Meningitis
Fungal Phylum Ascomycota
Fungal Phylum Microsporidia
Candidiasis
Overview of Fungi

